WO1982001990A1 - Ciment osseux - Google Patents
Ciment osseux Download PDFInfo
- Publication number
- WO1982001990A1 WO1982001990A1 PCT/NO1981/000044 NO8100044W WO8201990A1 WO 1982001990 A1 WO1982001990 A1 WO 1982001990A1 NO 8100044 W NO8100044 W NO 8100044W WO 8201990 A1 WO8201990 A1 WO 8201990A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silver
- bone cement
- volume
- protheses
- quartz
- Prior art date
Links
- 239000002639 bone cement Substances 0.000 title claims abstract description 16
- 239000002245 particle Substances 0.000 claims abstract description 17
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims abstract description 14
- 239000004926 polymethyl methacrylate Substances 0.000 claims abstract description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000010453 quartz Substances 0.000 claims abstract description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003365 glass fiber Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 8
- 210000001185 bone marrow Anatomy 0.000 claims abstract description 5
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000945 filler Substances 0.000 claims abstract description 4
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims abstract 4
- 229910052709 silver Inorganic materials 0.000 abstract description 7
- 239000004332 silver Substances 0.000 abstract description 7
- 239000004568 cement Substances 0.000 description 14
- 238000005452 bending Methods 0.000 description 5
- 210000001624 hip Anatomy 0.000 description 4
- -1 silver ions Chemical class 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229940100890 silver compound Drugs 0.000 description 2
- 150000003379 silver compounds Chemical class 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002436 femur neck Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- the invention relates to bone cement especially for cementing protheses, in particular protheses components for joint caps and bone marrow canals.
- the invention relates to a bone cement which is characterized by comprising polymethylmethacrylate, a filler material and a silver ion-releasing material.
- the new cement is substantially stronger than the cement used previously, as may be seen from the table found below.
- the increased strength is obtained by the addition of filler in the form of particles of glass fiber or quartz having a particle size of 4 - 8 microns.
- a silver ion-releasing material is also added to the cement, preferably in the form of colloidal silver having an express germicidal and anti-bacterial effect.
- Colloidal silver solutions are combinations of insoluble forms, of silver such as iodides, chlorides, oxides, etc., with protective colloids, usually organic.
- the insoluble forms of silver are precipitated in the presence of the protective colloids (for example, gelatins) in such manner that the particle size is very small and the particles do not settle but remain in suspension, and the resulting Liquid has many of the advantages of an actual solution.
- the protective colloids for example, gelatins
- These small particles of silver compounds act as reservoirs which release silver ions in a controlle manner and in small amounts; the actual concentration of silver ions will vary according to the nature of the silver compound present.
- this colloidal silver has a so-called oligodynamic effect, in that silver ions are continuously released over a long period of time.
- the silver ions will pass through the membrane of the bacteria and into the DNA molecule, in this way preventing propagation of the bacteria.
- the ratio of the three components of the bone cement mixture can vary as may be seen from the table founl below, which shows the results of tests carried out by Det Norske Veritas.
- the curing time is about 6 - 7 minutes and the curing temperature rises to about 90°C for a 10-mm thick layer.
- the curing time is 12-14 minutes under similar conditions.
- the curing time is 20-25 minutes, and. the curing temperature about 45°C. Since a curing time of as long as 20-25 minutes is impractical, the preferred bone cement comprises 65% polymethylmethacrylate with an addition of 30% quartz particles and 5% colloidal silver.
- the quartz particles are more irregular and thus provide a larger surface area, than glass fiber particles.
- the particle size for either quartz or glass fiber is between 4 and 8 microns.
- the larger surface area of the quartz particles may possibly help to make the cement less toxic by absorbing monomers, and one thereby also avoids the harmful high curing temperature. Bending tests were carried out at Det Norske Veritas on test rods made of polymethylmethacrylate alone and on test rods made of the bone cement of the invention. The results were as follows;
- A pure cement (polymethylmethacrylate).
- the bone cement of the invention should preferably be used for the cementing of protheses, especially protheses components in joint caps and bone marrow canals, and the results obtained up to now have been very satisfactory.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Dental Preparations (AREA)
- Materials For Medical Uses (AREA)
- Catalysts (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI822742A FI822742L (fi) | 1980-12-09 | 1982-08-06 | Bencement |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO803713801209 | 1980-12-09 | ||
NO803713A NO146306C (no) | 1980-12-09 | 1980-12-09 | Bensement og anvendelse derav. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1982001990A1 true WO1982001990A1 (fr) | 1982-06-24 |
Family
ID=19885784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NO1981/000044 WO1982001990A1 (fr) | 1980-12-09 | 1981-12-08 | Ciment osseux |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0066587A1 (fr) |
BE (1) | BE891374A (fr) |
DK (1) | DK352882A (fr) |
NO (1) | NO146306C (fr) |
WO (1) | WO1982001990A1 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0190504A2 (fr) * | 1984-12-28 | 1986-08-13 | Johnson Matthey Public Limited Company | Compositions antimicrobiennes |
EP0219058A2 (fr) * | 1985-10-09 | 1987-04-22 | Ernst Mühlbauer KG | Mélange polymérisable pour ciment |
DE10043151A1 (de) * | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Knochenzement mit antimikrobieller Wirksamkeit |
US7476698B2 (en) | 2001-09-18 | 2009-01-13 | Bio-Gate Ag | Antimicrobial adhesive and coating substance and method for the production thereof |
WO2009036862A2 (fr) | 2007-09-12 | 2009-03-26 | Trovotech Gmbh | Compositions à effet antimicrobien |
ITTO20090518A1 (it) * | 2009-07-10 | 2011-01-11 | Torino Politecnico | Cementi ossei compositi a matrice di pmma, contenenti vetri e vetroceramici bioattivi ed antibatterici |
EP2732830A1 (fr) | 2012-11-16 | 2014-05-21 | Heraeus Medical GmbH | Ciment osseux en polyméthylméthacrylate antiseptique |
DE102016212091A1 (de) | 2016-07-04 | 2018-01-04 | Heraeus Medical Gmbh | Antiseptischer Polymethylmethacrylat-Knochenzement |
US9872501B2 (en) | 2007-10-08 | 2018-01-23 | Johnson & Johnson Vision Care, Inc. | Methods for forming stabilized metal salt particles |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2347567A (en) * | 1943-03-11 | 1944-04-25 | Edward J Kresse | Dental implant |
US3932627A (en) * | 1974-02-04 | 1976-01-13 | Rescue Products, Inc. | Siver-heparin-allantoin complex |
DE2724814B2 (de) * | 1977-06-02 | 1979-07-26 | Kulzer & Co Gmbh, 6380 Bad Homburg | Vorprodukt für die Zubereitung von Knochenzement |
DE2906413A1 (de) * | 1978-02-22 | 1980-01-10 | S E P C S A R L Societe D Expl | Zement fuer prothesenimplantate |
WO1981002667A1 (fr) * | 1980-03-27 | 1981-10-01 | Nat Res Dev | Implants chirurgicaux antimicrobiens |
-
1980
- 1980-12-09 NO NO803713A patent/NO146306C/no unknown
-
1981
- 1981-12-07 BE BE0/206755A patent/BE891374A/fr not_active IP Right Cessation
- 1981-12-08 EP EP81903273A patent/EP0066587A1/fr not_active Withdrawn
- 1981-12-08 WO PCT/NO1981/000044 patent/WO1982001990A1/fr not_active Application Discontinuation
-
1982
- 1982-08-06 DK DK352882A patent/DK352882A/da unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2347567A (en) * | 1943-03-11 | 1944-04-25 | Edward J Kresse | Dental implant |
US3932627A (en) * | 1974-02-04 | 1976-01-13 | Rescue Products, Inc. | Siver-heparin-allantoin complex |
DE2724814B2 (de) * | 1977-06-02 | 1979-07-26 | Kulzer & Co Gmbh, 6380 Bad Homburg | Vorprodukt für die Zubereitung von Knochenzement |
DE2906413A1 (de) * | 1978-02-22 | 1980-01-10 | S E P C S A R L Societe D Expl | Zement fuer prothesenimplantate |
WO1981002667A1 (fr) * | 1980-03-27 | 1981-10-01 | Nat Res Dev | Implants chirurgicaux antimicrobiens |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0190504A2 (fr) * | 1984-12-28 | 1986-08-13 | Johnson Matthey Public Limited Company | Compositions antimicrobiennes |
EP0190504A3 (en) * | 1984-12-28 | 1987-05-20 | Johnson Matthey Public Limited Company | Antimicrobial compositions |
EP0219058A2 (fr) * | 1985-10-09 | 1987-04-22 | Ernst Mühlbauer KG | Mélange polymérisable pour ciment |
EP0219058A3 (en) * | 1985-10-09 | 1988-03-02 | Ernst Muhlbauer Kg | Polymerizable cement mixtures |
DE10043151A1 (de) * | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Knochenzement mit antimikrobieller Wirksamkeit |
US6984392B2 (en) * | 2000-08-31 | 2006-01-10 | Bio-Gate Bioinnovative Materials Gmbh | Antimicrobial material for implanting in bones |
EP1621217A2 (fr) | 2000-08-31 | 2006-02-01 | Bio-Gate Bioinnovative Materials GmbH | Poudre et matériau antimicrobiens |
EP1621217A3 (fr) * | 2000-08-31 | 2006-06-28 | Bio-Gate Bioinnovative Materials GmbH | Poudre et matériau antimicrobiens |
US7476698B2 (en) | 2001-09-18 | 2009-01-13 | Bio-Gate Ag | Antimicrobial adhesive and coating substance and method for the production thereof |
EP2234496A2 (fr) * | 2007-09-12 | 2010-10-06 | Trovotech Gmbh | Compositions a effet antimicrobien |
WO2009036862A2 (fr) | 2007-09-12 | 2009-03-26 | Trovotech Gmbh | Compositions à effet antimicrobien |
US9872501B2 (en) | 2007-10-08 | 2018-01-23 | Johnson & Johnson Vision Care, Inc. | Methods for forming stabilized metal salt particles |
ITTO20090518A1 (it) * | 2009-07-10 | 2011-01-11 | Torino Politecnico | Cementi ossei compositi a matrice di pmma, contenenti vetri e vetroceramici bioattivi ed antibatterici |
WO2011004355A2 (fr) | 2009-07-10 | 2011-01-13 | Politecnico Di Torino | Ciments osseux composites à matrice pmma, contenant des verres ou des vitrocéramiques antibactériens bioactifs |
WO2011004355A3 (fr) * | 2009-07-10 | 2011-10-13 | Politecnico Di Torino | Ciments osseux composites à matrice pmma, contenant des verres ou des vitrocéramiques antibactériens bioactifs |
EP2732830A1 (fr) | 2012-11-16 | 2014-05-21 | Heraeus Medical GmbH | Ciment osseux en polyméthylméthacrylate antiseptique |
DE102012022419A1 (de) | 2012-11-16 | 2014-05-22 | Heraeus Medical Gmbh | Antiseptischer Polymethylmethacrylat-Knochenzement |
US9833472B2 (en) | 2012-11-16 | 2017-12-05 | Heraeus Medical Gmbh | Antiseptic polymethylmethacrylate bone cement |
DE102016212091A1 (de) | 2016-07-04 | 2018-01-04 | Heraeus Medical Gmbh | Antiseptischer Polymethylmethacrylat-Knochenzement |
EP3266473A1 (fr) | 2016-07-04 | 2018-01-10 | Heraeus Medical GmbH | Ciment osseux en polyméthylméthacrylate antiseptique |
US10322207B2 (en) | 2016-07-04 | 2019-06-18 | Heraeus Medical Gmbh | Antiseptic polymethylmethacrylate bone cement |
Also Published As
Publication number | Publication date |
---|---|
BE891374A (fr) | 1982-03-31 |
DK352882A (da) | 1982-08-06 |
NO146306B (no) | 1982-06-01 |
NO146306C (no) | 1982-09-08 |
NO803713L (no) | 1982-06-01 |
EP0066587A1 (fr) | 1982-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Skallevold et al. | Bioactive glass applications in dentistry | |
Torabinejad et al. | Cytotoxicity of four root end filling materials | |
US4714721A (en) | Composite plastics-based material for prosthesis purposes | |
Vogel et al. | The development of bioglass ceramics for medical applications | |
US4150012A (en) | Discernible dental sealant | |
Homsy et al. | Materials for oral implantation—biological and functional criteria | |
US4866132A (en) | Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom | |
EP0244959B1 (fr) | Ciments verre/poly(acides carboxyliques) | |
US20040065228A1 (en) | Use of bioactive glass in dental filling material | |
Miyazaki et al. | Bioactive PMMA bone cement prepared by modification with methacryloxypropyltrimethoxysilane and calcium chloride | |
Carneiro et al. | Bioactivity and properties of an adhesive system functionalized with an experimental niobium-based glass | |
JPS6183108A (ja) | 硬化性歯科用修復材 | |
KR20070015393A (ko) | 치과 재료용 항균 첨가제로서 유리 조성물 | |
WO1982001990A1 (fr) | Ciment osseux | |
Fuchs et al. | Therapeutic ion-releasing bioactive glass ionomer cements with improved mechanical strength and radiopacity | |
Burnie et al. | Controlled release glasses (CRG) for biomedical uses | |
JP2001525778A (ja) | フッ化物イオン浸出性ガラスおよびそれらを含む歯科用セメント組成物 | |
Rae | Tolerance of mouse macrophages in vitro to barium sulfate used in orthopedic bone cement | |
JPS62503148A (ja) | 骨セメント | |
Cardoso et al. | Effect of root repair materials and bioactive glasses on microhardness of dentin | |
Leão et al. | The potential of a bioactive, pre-reacted, glass-ionomer filler resin composite to inhibit the demineralization of enamel in vitro | |
JP3942667B2 (ja) | フッ化物放出歯科用組成物 | |
Pokharkar et al. | Comparative evaluation of bioactivity, fluoride release, shear bond strength, and compressive strength of conventional glass ionomer cement incorporated with three inorganic bioactive nanoparticles: An experimental analysis | |
Kumar et al. | Comparative evaluation of shear bond strength of tricalcium silicate-based materials to composite resin with two different adhesive systems: an in vitro study | |
JPS59146658A (ja) | 生物反応性材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): AT CH DE DK FI GB NL SE US |
|
AL | Designated countries for regional patents |
Designated state(s): AT CH DE FR GB NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1981903273 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 822742 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1981903273 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1981903273 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |